GB909126A - 16ª--17ª--alkylidenedioxy steroids and process for preparation - Google Patents
16ª--17ª--alkylidenedioxy steroids and process for preparationInfo
- Publication number
- GB909126A GB909126A GB836659A GB836659A GB909126A GB 909126 A GB909126 A GB 909126A GB 836659 A GB836659 A GB 836659A GB 836659 A GB836659 A GB 836659A GB 909126 A GB909126 A GB 909126A
- Authority
- GB
- United Kingdom
- Prior art keywords
- steroids
- hal
- prepared
- dione
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000007062 hydrolysis Effects 0.000 abstract 3
- 238000006460 hydrolysis reaction Methods 0.000 abstract 3
- 229910014455 Ca-Cb Inorganic materials 0.000 abstract 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 abstract 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- JRMAQQQTXDJDNC-UHFFFAOYSA-M 2-ethoxy-2-oxoacetate Chemical compound CCOC(=O)C([O-])=O JRMAQQQTXDJDNC-UHFFFAOYSA-M 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 235000019256 formaldehyde Nutrition 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000002140 halogenating effect Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000005735 osmylation reaction Methods 0.000 abstract 1
- 229960002317 succinimide Drugs 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises steroids of the formula <FORM:0909126/IV (b)/1> (wherein :Cc-Cd-Ceis :C(a Hal).CH(OH). CH2-, :CH.CH(OH).CH(a Hal)-, :C(a Hal). CO.CH2-, :CH.CO.CH(a Hal)-, :C=CH-CH2, :C-CH=CH-, <FORM:0909126/IV (b)/2> :CH-CO.CH2-, :CH.CH(a or b OH).CH2-, <FORM:0909126/IV (b)/3> or :C(a Hal).CH(O alkanoyl). CH2-, A and B are hydrogen atoms or alkyl groups, Ca-Cb is -CH2CH2-, -CH=CH-, -CH2CH(CH3)- or -CH=C(CH3)- and Y is CH3, CH2OH or CH2O alkanoyl, the alkyl and alkanoyl groups each containing at most 6 carbon atoms); and their preparation (1) by reacting the corresponding 16 : 17-dihydroxy steroids with the appropriate aldehyde or ketone; (2) for compounds wherein the substituents in the 9:11-positions are 9a -halo-11b -hydroxy or 9b :11b -oxido by treating the corresponding 9(11)-unsaturated steroids with an N-halo-succinimide or -acetamide in presence of an acid, dehydrohalogenating if desired to form the 9b :11b -oxido steroids and if desired reacting these with the appropriate halo acid to form the 9a -halo-11b -hydroxy steroids again; (3) for compounds wherein Ca-Cb is CH=CH-, by halogenating the corresponding 2-alkoxyoxalyl-3-keto-D 4-16a :17a -alkylidenedioxy steroid, heating the resulting mixture with a base and dehydrohalogenating e.g. with a tertiary amine; (4) for compounds wherein the substituent in the 11-position is a keto group, by treating the corresponding 11-hydroxy steroids with chromic anhydride; and (5) for 21-alkanoyloxy-steroids, by acylation of the corresponding 21-hydroxysteroids. Detailed examples are given and the hydrolysis of a 21-acylate to a 21-ol also is described. 16a :17a -Dihydroxy-steroids are prepared by hydroxylation of the corresponding D 16-steroids, for example by osmylation and hydrolysis. 2 - Ethoxyoxalyl - 16a :17a - isopropylidenedioxy-4:9(11)-pregnadiene-3:20-dione is prepared from the corresponding 2-unsubstituted steroid and ethyl oxalate. 11b - Acetoxy - 9a - fluoro - 16a :17a :21-trihydroxy-1:4-pregnadiene-3:20-dione is prepared by partial hydrolysis of the 11b :16a :21-triacetoxy compound. 11a - Methanesulphonyloxy - 16a :17a - iso - propylidenedioxy-4-pregnene-3:20-dione is prepared from the 11a -hydroxy compound and methanesulphonyl chloride. 9a - Bromo - 11b :16a :17a -trihydroxy-4-pregnene-3:20-dione is prepared from the D 9(11)-compound and N-bromosuccinimide. Reference has been directed by the Comptroller to Specification 889,765.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72056458A | 1958-03-11 | 1958-03-11 | |
| US742742A US2990401A (en) | 1958-06-18 | 1958-06-18 | 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB909126A true GB909126A (en) | 1962-10-24 |
Family
ID=27110277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB836659A Expired GB909126A (en) | 1958-03-11 | 1959-03-11 | 16ª--17ª--alkylidenedioxy steroids and process for preparation |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB909126A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0072989A1 (en) * | 1981-08-21 | 1983-03-02 | Schering Aktiengesellschaft | Corticoids, their preparation and their utilization |
| US4404200A (en) * | 1980-12-04 | 1983-09-13 | Aktiebolaget Draco | 4-Pregnene-derivatives, a process for their preparation, composition and method for the treatment of inflammatory conditions |
-
1959
- 1959-03-11 GB GB836659A patent/GB909126A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4404200A (en) * | 1980-12-04 | 1983-09-13 | Aktiebolaget Draco | 4-Pregnene-derivatives, a process for their preparation, composition and method for the treatment of inflammatory conditions |
| EP0072989A1 (en) * | 1981-08-21 | 1983-03-02 | Schering Aktiengesellschaft | Corticoids, their preparation and their utilization |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE58149B1 (en) | 11 beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them | |
| GB996080A (en) | 17-monoesters of 17ª,21-dihydroxy steroids and process for the preparation thereof | |
| GB909126A (en) | 16ª--17ª--alkylidenedioxy steroids and process for preparation | |
| GB869511A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| GB1075545A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| GB1416277A (en) | 3-keto-7 a or beta-lower alkyl-delta5-steroids and process for preparing same | |
| US3577410A (en) | 13beta-alkyl-17-hydroxygona-4,14-dien-3-ones | |
| US3055916A (en) | 2-halo-delta2 androsten derivatives and process | |
| US3461118A (en) | 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof | |
| US3705182A (en) | 16beta-difluoromethyl and 16-difluoromethylene steroids and processes for their preparation | |
| US3290297A (en) | Tetrahydrofuranyl ethers of delta1, 3, 5(10)-estratriene | |
| US3365473A (en) | 13beta-lower alkyl gona-4, 8(14)-dien-3-ones 17 beta process for the production thereof | |
| US3099664A (en) | 7-cyano androstane compounds | |
| US3629301A (en) | 3 3-difluoro-2-substituted steroids and their preparation | |
| DE1493145B1 (en) | 3-Hydroxyl-1,5-bisdehydro-steroids of the androstane series that are unsubstituted in the 4-position | |
| GB959378A (en) | 21-substituted 17ª, 21-dioxy steroids and processes for their preparation | |
| GB1063816A (en) | 10-a-methyl steroids | |
| US3188326A (en) | 2-methyl derivatives of delta2-androsten-17beta-ol | |
| Fukushima et al. | Synthesis and reactions of 3, 11β-dihydroxy-Δ4-androsten-17-one | |
| GB1073988A (en) | Process for preparing steroid compounds, and the compounds thus prepared | |
| ES336023A1 (en) | 6-Keto-Steroids and Process for their Manufacture from 20-Formyl-6-Keto-Steroids | |
| GB1063662A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| US2976302A (en) | Process for the production of 2, 2-dialkyl androstane compounds | |
| US3019240A (en) | 6alpha-cyano progesterone and derivatives thereof | |
| US3634467A (en) | 1alpha 2alpha-methylene-6-trifluoromethyl steroids |